J2350 Injection, ocrelizumab, 1 milligrams
J-Codes
Also known as: ocrelizumab, Ocrevus, CD20 antibody
Injection of ocrelizumab, 1 milligram. A monoclonal antibody targeting CD20 on B cells for MS.
Clinical Context
Used for relapsing and primary progressive multiple sclerosis. Ocrelizumab selectively depletes CD20+ B cells involved in MS pathogenesis.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.